A clinical trial of the efficacy and acceptability of D-fenfluramine in the treatment of neuroleptic-induced obesity
- PMID: 2908235
- DOI: 10.1192/bjp.153.2.208
A clinical trial of the efficacy and acceptability of D-fenfluramine in the treatment of neuroleptic-induced obesity
Abstract
Twenty-nine overweight schizophrenic patients maintained on depot neuroleptic injections who wished to lose weight took part in a double-blind, placebo-controlled trial of 30 mg D-fenfluramine. All subjects received dietary advice. Sixteen patients completed the 12-week trial. Rate of weight loss was significantly greater in those taking D-fenfluramine. Side-effects were reported, but no deterioration in mental state was noted.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
